FDA floats relaxation of regulations to encourage use of mass spectrometry to identify microorganisms
The FDA is planning to loosen the regulatory requirements on mass spectrometry devices to increase their use in the identification of microorganisms. Agency officials outlined the plan after signing off on the use of a mass spectrometry device in the identification of the emerging drug-resistant yeast, Candida auris (C. auris).
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063